RBC Capital lowered the firm’s price target on Synovus (SNV) to $58 from $65 and keeps an Outperform rating on the shares. The company reported a solid quarter with a lower loan loss provision and better core revenue trends as drivers, the analyst tells investors in a research note. RBC adds that it expects relative margin stability in the medium term, though given the asset sensitivity of the balance sheet, rate decreases are a “short term headwind”.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SNV: